Novartis and Alcon Agree to Pay $345 Million to Resolve Corruption Charges

IMPORTANT: The full content of this page is available to premium users only.

Friday, July 3, 2020
Bruce Zagaris

On June 25, 2020, Novartis Hellas S.A.C.I. (Novartis Greece), a subsidiary of Novartis AG, a Swiss-based global pharmaceutical company, and Alcon Pte Ltd., a former subsidiary of Novartis AG and current subsidiary of multinational eye care company Alcon Inc., have agreed to pay more than $233 million in criminal monetary penalties to resolve the U.S. Department of Justice’s investigation into violations of the Foreign Corrupt Practices Act (FCPA).[1]

[1]    U.S. Department of Justice, 2020 Novartis Hellas S.A.C.I. and Alcon Pte Ltd Agree to Pay over $233 Million Combined to Resolve Criminal FCPA Cases, June 25, 2020.